In conclusion, our studies suggested that FOXP3 inhibited HCC progression by enhancing the phosphorylation of TGF-β RI and activating TGF-β/Smad2/3 signaling pathway. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.